LAKSHMANA KOORAGAYALA, MD
Ophthalmology Physician · MARIETTA, GA
Individual Active NPI 1497757496
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 728 | 17,343 | $8,915,274 | $2,645,477 | $2,077,057 |
| 2023 | 708 | 15,299 | $6,286,657 | $2,404,240 | $1,885,582 |
| 2022 | 750 | 9,165 | $5,502,545 | $2,276,407 | $1,789,472 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 6,660 | $35 | $27 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 2,020 | $109 | $87 |
| 92134 | Imaging of retina | 1,746 | $40 | $30 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,568 | $332 | $264 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,515 | $147 | $117 |
| 67028 | Injection of drug into eye | 996 | $128 | $91 |
| J0178 | Injection, aflibercept, 1 mg | 880 | $827 | $657 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 478 | $92 | $66 |
| 92014 | Established patient complete exam of visual system | 429 | $126 | $86 |
| J2778 | Injection, ranibizumab, 0.1 mg | 227 | $158 | $125 |
| J9035 | Injection, bevacizumab, 10 mg | 79 | $71 | $54 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 70 | $129 | $90 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 056191 | GA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Georgia
- NPI 1154383438
- NPI 1770791725
- NPI 1164786976
- NPI 1962668046
- NPI 1215348859
- NPI 1306810080
- NPI 1720160922
- NPI 1750690848
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.